- The stock price of Natera (NASDAQ: NTRA) increased by over 20% during intraday trading today. This is why.
The stock price of Natera (NASDAQ: NTRA) increased by over 20% during intraday trading today. This is a bounce back following a drop of over 47% yesterday.
The stock price dropped yesterday due to a short seller report from Hindenburg Research.
Hindenburg Research said that based on over 2 dozen interviews with former Natera employees, patients and industry experts, a review of hundreds of online complaints, FOIA requests to state Medicaid offices and state Attorneys General, and the company’s financial filings, the short seller shows how Natera’s revenue growth has been fueled by deceptive sales and billing practices aimed at doctors, insurance companies and expectant mothers.
“The company has never generated a profit and posted a $468.2 million loss from operations in 2021 compared to $216.3 million in 2020. It has an accumulated deficit of $1.4 billion and currently has $914.5 million in cash and equivalents and $330.4 million in debt,” wrote Hindenburg in the report.
But Natera issued a response saying that they “disagree with the accuracy of this report which was generated in an attempt to make a quick profit by short sellers Hindenburg Research, who are currently under criminal investigation by the Department of Justice for illegal trading tactics. This is the same story short sellers have been pitching for many years.”
Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.